DiviDrip · AARD

AARD — Aardvark Therapeutics, Inc.

AARD is Aardvark Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $5.73. Market cap: $125M. Capital Quality Rank: 52/100 — Above average.

Stock snapshot

Price$5.73
Market cap$125M
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)52 / 100 · Above average
ROIC (TTM)-18.3%
Altman Z-score zoneSafe

About AARD

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Listed2025Employees28HQSan Diego, CASectorHealthcareWebsiteaardvarktherapeutics.com

Related non-dividend companies

Other non-dividend stocks investors research alongside AARD. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is AARD's current stock price?

AARD (Aardvark Therapeutics, Inc.) is currently trading at $5.73.

Does AARD pay a dividend?

AARD (Aardvark Therapeutics, Inc.) does not currently pay a regular dividend.

What is AARD's Capital Quality Rank?

AARD has a Capital Quality Rank of 52/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track AARD in DiviDrip

Add AARD to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow